Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Multilevel Integrated Model with a Novel Systems Approach (MIMANSA) for Simulating the Spread of COVID-19

Arpita Welling, Abhilasha Patel, Padmaj Kulkarni, View ORCID ProfileVinay G. Vaidya
doi: https://doi.org/10.1101/2020.05.12.20099291
Arpita Welling
1Applied Research Group, Pi Innovate, Pune, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abhilasha Patel
1Applied Research Group, Pi Innovate, Pune, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Padmaj Kulkarni
3Department of Medical Oncology, Deenanath Mangeshkar Hospital, Pune, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vinay G. Vaidya
1Applied Research Group, Pi Innovate, Pune, India
2Department of Technology, Savitribai Phule Pune University, Pune, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vinay G. Vaidya
  • For correspondence: vaidya.vinay@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Due to the spread of the coronavirus, public health officials grapple with multiple issues such as recommending a lockdown, contact tracing, promoting the use of masks, social distancing, frequent handwashing, as well as quarantining. It is even more challenging to find the optimal combination of these factors without the use of a suitable mathematical model.

In this paper, we discuss a novel systems approach to building a model for simulating the spread of COVID-19. The model, MIMANSA, divides an individual’s in-person social interactions into three areas, namely home, workplace, and public places. The model tracks the in-person interactions and follows the virus spread. When a new silent carrier is created, the model automatically expands and builds a new layer in the network.

MIMANSA has four control mechanisms, namely the exposure, infection rate, lockdown, and quarantining. MIMANSA differentiates between virus-infected patients, silent carriers, and healthy carriers. It can consider variations in virus activity levels of asymptomatic patients, varying the exposure to the virus, and varying the infection rate depending on the person’s immunity. MIMANSA can simulate scenarios to study the impact of many different conditions simultaneously. It could assist public health officials in complex decision making, enable scientists in projecting the SARS-CoV-2 virus spread and aid hospital administrators in the management of beds and equipment.

MIMANSA is trained and validated using the data from the USA and India. Our results show that MIMANSA forecasts the number of COVID-19 cases in the USA, and India within a 3% margin of error.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

None

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not required

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data was obtained from the link given below. covid19india.org kaggle.com

https:www.covid19India.org

https://www.kaggle.com/imdevskp/corona-virus-report

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 18, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Multilevel Integrated Model with a Novel Systems Approach (MIMANSA) for Simulating the Spread of COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Multilevel Integrated Model with a Novel Systems Approach (MIMANSA) for Simulating the Spread of COVID-19
Arpita Welling, Abhilasha Patel, Padmaj Kulkarni, Vinay G. Vaidya
medRxiv 2020.05.12.20099291; doi: https://doi.org/10.1101/2020.05.12.20099291
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Multilevel Integrated Model with a Novel Systems Approach (MIMANSA) for Simulating the Spread of COVID-19
Arpita Welling, Abhilasha Patel, Padmaj Kulkarni, Vinay G. Vaidya
medRxiv 2020.05.12.20099291; doi: https://doi.org/10.1101/2020.05.12.20099291

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (144)
  • Anesthesia (47)
  • Cardiovascular Medicine (419)
  • Dentistry and Oral Medicine (72)
  • Dermatology (49)
  • Emergency Medicine (147)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (174)
  • Epidemiology (4906)
  • Forensic Medicine (3)
  • Gastroenterology (185)
  • Genetic and Genomic Medicine (689)
  • Geriatric Medicine (72)
  • Health Economics (193)
  • Health Informatics (636)
  • Health Policy (322)
  • Health Systems and Quality Improvement (209)
  • Hematology (86)
  • HIV/AIDS (157)
  • Infectious Diseases (except HIV/AIDS) (5408)
  • Intensive Care and Critical Care Medicine (333)
  • Medical Education (96)
  • Medical Ethics (24)
  • Nephrology (77)
  • Neurology (692)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (128)
  • Occupational and Environmental Health (211)
  • Oncology (447)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (91)
  • Pain Medicine (37)
  • Palliative Medicine (18)
  • Pathology (131)
  • Pediatrics (201)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (88)
  • Psychiatry and Clinical Psychology (787)
  • Public and Global Health (1832)
  • Radiology and Imaging (328)
  • Rehabilitation Medicine and Physical Therapy (142)
  • Respiratory Medicine (257)
  • Rheumatology (87)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (63)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (38)